ArticleCureus2025
Systemic Lupus Erythematosus as a Risk Factor for Encapsulating Peritoneal Sclerosis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on abdominal cocoon syndrome.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Encapsulating peritoneal sclerosis (EPS) refers to the insidious formation of a thick fibrous cocoon encasing the intra-abdominal organs and may lead to bowel obstruction. EPS is a known but rare complication of chronic peritoneal dialysis (PD) due to the long-term exposure of glucose degradation products and recurrent peritonitis, promoting inflammatory fibrosis and sclerosis of intra-abdominal structures. However, PD patients with systemic lupus erythematosus (SLE) may be at increased risk of developing EPS due to the concurrent immune-mediated inflammation of the peritoneal serosa. This report describes the case of a young female with SLE and end-stage renal disease (ESRD) due to lupus nephritis who developed EPS after five years of PD. Her clinical course was complicated by septic shock and pneumoperitoneum; exploratory laparotomy revealed diffuse fibrous encapsulation of the liver, transverse colon, and stomach requiring surgical enterolysis. This case highlights the role of SLE as an important risk factor for EPS and underscores the need for preventive measures among this high-risk population of chronic PD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.